89BIO INC (ETNB) Stock Income Statement
NASDAQ:ETNB - Nasdaq - US2825591033 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 384.66M | 151.20M | 102.25M | 89.74M | 49.36M | |||
| Research and Development | 345.04M | 122.23M | 80.80M | 70.33M | 36.20M | |||
| Selling, General, and Administrative Expenses | 39.62M | 28.97M | 21.45M | 19.41M | 13.16M | |||
| Operating Income | -384.66M | -151.20M | -102.25M | -89.74M | -49.36M | |||
| Interest Income/Expense | 19.77M | 14.08M | 240.00K | -530.00K | N/A | |||
| Other Income/Expense | N/A | N/A | N/A | -126.00K | -200.00K | |||
| Non Recurring Items | -1.50M | -1.20M | N/A | N/A | N/A | |||
| Income Before Taxes | -366.39M | -138.32M | -102.01M | -90.27M | -49.56M | |||
| Income Tax | 692.00K | 3.87M | 20.00K | -150.00K | -60.00K | |||
| Net Income | -367.08M | -142.19M | -102.03M | -90.12M | -49.50M | |||
| EBITDA | -384.62M | -151.15M | -102.18M | -89.66M | -49.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.51 | -2.00 | -2.93 | -4.48 | -3.08 | |||
| Non GAAP EPS | -3.43 | -2.01 | -3.54 | -4.48 | -3.10 | |||
| Statistics | ||||||||
All data in USD